Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony Mato, MD
University of Pennsylvania Center for CLL
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tg Therapeutics Investigational Trial Site
Huntsville, Alabama, United States
- Tg Therapeutics Investigational Trial Site
Washington D.C., District of Columbia, United States
- Tg Therapeutics Investigational Trial Site
Fort Myers, Florida, United States
- Tg Therapeutics Investigational Trial Site
St. Petersburg, Florida, United States
- Tg Therapeutics Investigational Trial Site
Kansas City, Missouri, United States
- Tg Therapeutics Investigational Trial Site
Lebanon, New Hampshire, United States
- Tg Therapeutics Investigational Trial Site
Hackensack, New Jersey, United States
- Tg Therapeutics Investigational Trial Site
New Hyde Park, New York, United States
- Tg Therapeutics Investigational Trial Site
New York, New York, United States
- Tg Therapeutics Investigational Trial Site
Rochester, New York, United States
- Tg Therapeutics Investigational Trial Site
Durham, North Carolina, United States
- Tg Therapeutics Investigational Trial Site
Hershey, Pennsylvania, United States
- Tg Therapeutics Investigational Trial Site
Philadelphia, Pennsylvania, United States
- Tg Therapeutics Investigational Trial Site
Nashville, Tennessee, United States
- Tg Therapeutics Investigational Trial Site
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Apr 2016
- Primary completion
- 10 Jun 2021
- Completion
- 10 Jun 2021
- Last update posted
- 3 Jul 2024
- Registered enrollment
- 51
- Registry id
- NCT02742090
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.